Rectal Adenocarcinoma — Trials

Rectal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 28
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06834126	Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial	recruiting	Phase 1	36	City of Hope Medical CenterOTHER	1	Jul 22, 2026	clinicaltrials
NCT04703101	Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer	recruiting	Phase 1	25	Jonsson Comprehensive Cancer CenterOTHER	1	Mar 30, 2026	clinicaltrials